These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8451009

  • 1. Aspartame use in Parkinson's disease.
    Karstaedt PJ, Pincus JH.
    Neurology; 1993 Mar; 43(3 Pt 1):611-3. PubMed ID: 8451009
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure.
    Gupta V, Cochran C, Parker TF, Long DL, Ashby J, Gorman MA, Liepa GU.
    Am J Clin Nutr; 1989 Jun; 49(6):1302-6. PubMed ID: 2729170
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bioavailability of phenylalanine and aspartate from aspartame (20 mg/kg) in capsules and solution.
    Burns TS, Stargel WW, Hurwitz A.
    Metabolism; 1990 Nov; 39(11):1200-3. PubMed ID: 2233283
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aspartame, behavior, and cognitive function in children with attention deficit disorder.
    Shaywitz BA, Sullivan CM, Anderson GM, Gillespie SM, Sullivan B, Shaywitz SE.
    Pediatrics; 1994 Jan; 93(1):70-5. PubMed ID: 7505423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A balanced carbohydrate: protein diet in the management of Parkinson's disease.
    Berry EM, Growdon JH, Wurtman JJ, Caballero B, Wurtman RJ.
    Neurology; 1991 Aug; 41(8):1295-7. PubMed ID: 1866021
    [Abstract] [Full Text] [Related]

  • 12. Aspartame: review of recent experimental and observational data.
    Janssen PJ, van der Heijden CA.
    Toxicology; 1988 Jun; 50(1):1-26. PubMed ID: 3291200
    [Abstract] [Full Text] [Related]

  • 13. Effect of aspartame and protein, administered in phenylalanine-equivalent doses, on plasma neutral amino acids, aspartate, insulin and glucose in man.
    Møller SE.
    Pharmacol Toxicol; 1991 May; 68(5):408-12. PubMed ID: 1946186
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Administration of aspartame in non-insulin-dependent diabetics.
    Stern SB, Bleicher SJ, Flores A, Gombos G, Recitas D, Shu J.
    J Toxicol Environ Health; 1976 Nov; 2(2):429-39. PubMed ID: 1011296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame.
    Hjelle JJ, Dudley RE, Marietta MP, Sanders PG, Dickie BC, Brisson J, Kotsonis FN.
    Pharmacology; 1992 Nov; 44(1):48-60. PubMed ID: 1553388
    [Abstract] [Full Text] [Related]

  • 20. Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in individuals heterozygous for phenylketonuria.
    Stegink LD, Filer LJ, Baker GL, Bell EF, Ziegler EE, Brummel MC, Krause WL.
    Metabolism; 1989 Jan; 38(1):78-84. PubMed ID: 2909831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.